Media Center
News
MediThinQ and Synovis MCA Announce Strategic Global Distribution Agreement for SHIYA
MediThinQ has entered into a strategic global distribution agreement with Synovis Micro Companies Alliance (SMCA), a Baxter company, for the worldwide commercialization of the SHIYA platform.
The collaboration expands global access to advanced 3D surgical visualization through SMCA’s established commercial network.
The agreement represents a significant milestone in MediThinQ’s global commercialization strategy.
News
Baxter’s Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
Baxter’s subsidiary, Synovis MCA, has signed a multi-year global distribution agreement with MediThinQ.
Under this deal, Synovis MCA will lead the worldwide commercialization and rollout of MediThinQ’s next-generation 3D surgical visualization platform, SHIYA.
The SHIYA platform combines a 3D digital exoscope with the wearable display SCOPEYE, aiming to accelerate the digital transformation of global microsurgery.
News
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
MediThinQ announced a global distribution agreement with Synovis Micro Companies Alliance (SMCA), a Baxter company, to accelerate worldwide commercialization of the SHIYA 3D surgical visualization platform.
The partnership aims to expand global access to advanced microsurgical visualization through SMCA’s established commercial network.
News
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
MediThinQ, a fast-growing innovator in surgical displays and digital 3D microscopy, today announced that world-renowned reconstructive microsurgeon Prof. Joon-pio Hong has joined the company as Chief Medical Officer. His decision marks one of the strongest clinical endorsements to date for MediThinQ’s next-generation digital microsurgery platform, SHIYA 20.
News
MediThinQ Signs Exclusive Supply Agreement with China’s Sinopharm
MediThinQ has signed an exclusive supply agreement with Sinopharm, China’s largest state-owned medical and pharmaceutical distribution company.
Through this partnership, MediThinQ will enter China’s medical device market with its flagship surgical display solution, SCOPEYE.
SCOPEYE provides high-definition surgical images in real time, helping improve surgical precision, ergonomics, and medical training.
MediThinQ plans to use this agreement as a foundation for broader expansion across Asia and the global medical device market.
News
MediThinQ nabs exclusive supply deal with Medtronic
MediThinQ, the first South Korean healthcare startup nurtured by healthcare startup accelerator VentureBlick, inked an exclusive….
News
MediThinQ launches new micro surgery solution
Korean startup MediThinQ has announced the launch of its SCOPEYE 3D Micro Surgery Solution, which uses the latest Eyes Up Display technol…
News
MediThinQ to launch medical AR device in Japan
MediThinQ, a local medical wearable company, will launch its medical augmented reality (AR) displaying device in Japan in November, utilizing a partnership with medical device….
메디씽큐 임승준 대표,
“수술 시야 혁신으로 스마트 수실실 시대 연다”
바이오타임즈 신서경 기자 ｜2026.06.19
- 무선 3D 시각화 기술 기반 의료 솔루션 개발
- SHIYA·SCOPEYE 통해 수술 영상 공유·기록 플랫폼 확장
- 2027년 기술특례상장 목표…글로벌 시장 공략 본격화